by ASH Publications
Clinical trial evidence supports the use of itacitinib plus routine prophylaxis to prevent graft-versus-host disease (GVHD) and cytokine release syndrome (CRS) following haploidentical...
by Nature
As the stem cell transplantation (SCT) landscape has evolved, scientists say the balance between graft-versus-leukemia (GVL) and graft-versus-host disease (GVHD) effects has also shifted.
by Blood Advances
Scientists believe a tetravalent bispecific antibody (BsAb) might effectively combat graft-versus-host disease (GVHD), a common complication of allogeneic hematopoietic stem cell transplantation.
by Nature
Researchers believe treatment with an antibacterial enzyme specific to Enterococcus faecalis may provide prophylaxis against acute graft-versus-host disease (aGVHD).
by Blood Advances
Although HLA-matched sibling donors (MSDs) are considered the gold standard for hematopoietic cell transplantation (HCT), evidence suggests comparable outcomes are possible with haploidential...
by Alex Kadhim
In a recent study led by Roswell Park Comprehensive Cancer Center, researchers have found that posttransplant cyclophosphamide (PTCy) leads to unique changes in vascular biomarkers, revealing a...